Ubiquitin Ligases in Cancer: Ushers for Degradation
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 25 (6) , 502-513
- https://doi.org/10.1080/07357900701508041
Abstract
The regulated degradation of cellular proteins by the ubiquitin-proteasome system impacts a range of vital cellular processes in both normal and cancerous cells. An ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase (E3) catalyzes the conjugation of the protein ubiquitin to a target protein and, thereby, tags that protein for recognition and destruction by the proteasome. Ubiquitin ligases are particularly interesting because they determine substrate selection. This review examines the role of dysregulated ubiquitin ligase activity in the development and progression of various cancers, and highlights why ubiquitin ligases have emerged as extremely attractive targets for therapeutic intervention in a number of human malignancies.Keywords
This publication has 102 references indexed in Scilit:
- Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topologyNature Cell Biology, 2006
- Activation of IKK by TNFα Requires Site-Specific Ubiquitination of RIP1 and Polyubiquitin Binding by NEMOMolecular Cell, 2006
- Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activationNature Cell Biology, 2006
- The Evi5 Oncogene Regulates Cyclin Accumulation by Stabilizing the Anaphase-Promoting Complex Inhibitor Emi1Cell, 2006
- Ubiquitylation and cell signalingThe EMBO Journal, 2005
- Ubiquitin-binding domainsNature Reviews Molecular Cell Biology, 2005
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin ChainPublished by Elsevier ,2000
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996